MovDisordV3, PascalFrancis, Corpus, bibRecord, 002729

Effects of apomorphine on flexor reflex and periodic limb movement

Identifieur interne : 002729 ( PascalFrancis/Corpus ); précédent : 002728; suivant : 002730

Effects of apomorphine on flexor reflex and periodic limb movement

Auteurs : Guillermo Paradiso ; Farooq Khan ; Robert Chen

Source :

Movement disorders [ 0885-3185 ] ; 2002.

RBID : Pascal:02-0369774

Descripteurs français

Pascal (Inist)
- Mouvement périodique, Membre inférieur, Impatience membre inférieur syndrome, Réflexe, Muscle fléchisseur, Apomorphine, Agoniste, Récepteur dopaminergique, Electromyographie, Stimulant dopaminergique, Pathogénie, Effet biologique, Etude cas, Personne âgée, Mâle.

English descriptors

KwdEn :
- Agonist, Biological effect, Case study, Dopamine agonist, Dopamine receptor, Elderly, Electromyography, Flexor muscle, Lower limb, Male, Pathogenesis, Periodic motion, Reflex, Restless legs syndrome.

Abstract

It has been suggested that periodic leg movements (PLM) and spinal flexor reflex (FR) share common mechanisms Although dopaminergic agents improve PLM in humans and strongly influence spinal FR circuitry in animal studies, its effects on FR have not been documented in humans. We describe a 65-year-old man with PLM after overnight withdrawal of dopaminergic agents. The electromyographic pattern of spontaneous PLM closely resembled that of the FR elicited by medial plantar nerve stimulation. Thirty minutes after subcutaneous injection of apomorphine, both PLM and FR were completely abolished. These findings demonstrate that dopaminergic agents can suppress exaggerated FR in humans, and support the hypothesis of common mechanisms for PLM and FR.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 17`
A06				`@2 3`
A08	`01`	`1`	`ENG`	`@1 Effects of apomorphine on flexor reflex and periodic limb movement`
A11	`01`	`1`		`@1 PARADISO (Guillermo)`
A11	`02`	`1`		`@1 KHAN (Farooq)`
A11	`03`	`1`		`@1 CHEN (Robert)`
A14	`01`			`@1 Division of Neurology, Toronto Western Hospital and The Toronto Western Research Institute, University Health Network, University of Toronto @2 Toronto, Ontario @3 CAN @Z 1 aut. @Z 2 aut. @Z 3 aut.`
A20				`@1 594-597`
A21				`@1 2002`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000108224770260`
A44				`@0 0000 @1 © 2002 INIST-CNRS. All rights reserved.`
A45				`@0 12 ref.`
A47	`01`	`1`		`@0 02-0369774`
A60				`@1 P @3 CC`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 It has been suggested that periodic leg movements (PLM) and spinal flexor reflex (FR) share common mechanisms Although dopaminergic agents improve PLM in humans and strongly influence spinal FR circuitry in animal studies, its effects on FR have not been documented in humans. We describe a 65-year-old man with PLM after overnight withdrawal of dopaminergic agents. The electromyographic pattern of spontaneous PLM closely resembled that of the FR elicited by medial plantar nerve stimulation. Thirty minutes after subcutaneous injection of apomorphine, both PLM and FR were completely abolished. These findings demonstrate that dopaminergic agents can suppress exaggerated FR in humans, and support the hypothesis of common mechanisms for PLM and FR.
C02	`01`	`X`		`@0 002B17A01`
C03	`01`	`X`	`FRE`	`@0 Mouvement périodique @5 01`
C03	`01`	`X`	`ENG`	`@0 Periodic motion @5 01`
C03	`01`	`X`	`SPA`	`@0 Movimiento periódico @5 01`
C03	`02`	`X`	`FRE`	`@0 Membre inférieur @5 02`
C03	`02`	`X`	`ENG`	`@0 Lower limb @5 02`
C03	`02`	`X`	`SPA`	`@0 Miembro inferior @5 02`
C03	`03`	`X`	`FRE`	`@0 Impatience membre inférieur syndrome @5 04`
C03	`03`	`X`	`ENG`	`@0 Restless legs syndrome @5 04`
C03	`03`	`X`	`SPA`	`@0 Acroparestesia nocturna @5 04`
C03	`04`	`X`	`FRE`	`@0 Réflexe @5 07`
C03	`04`	`X`	`ENG`	`@0 Reflex @5 07`
C03	`04`	`X`	`SPA`	`@0 Reflejo @5 07`
C03	`05`	`X`	`FRE`	`@0 Muscle fléchisseur @5 08`
C03	`05`	`X`	`ENG`	`@0 Flexor muscle @5 08`
C03	`05`	`X`	`SPA`	`@0 Músculo flexor @5 08`
C03	`06`	`X`	`FRE`	`@0 Apomorphine @2 NK @2 FR @5 10`
C03	`07`	`X`	`FRE`	`@0 Agoniste @5 11`
C03	`07`	`X`	`ENG`	`@0 Agonist @5 11`
C03	`07`	`X`	`SPA`	`@0 Agonista @5 11`
C03	`08`	`X`	`FRE`	`@0 Récepteur dopaminergique @5 12`
C03	`08`	`X`	`ENG`	`@0 Dopamine receptor @5 12`
C03	`08`	`X`	`SPA`	`@0 Receptor dopaminérgico @5 12`
C03	`09`	`X`	`FRE`	`@0 Electromyographie @5 13`
C03	`09`	`X`	`ENG`	`@0 Electromyography @5 13`
C03	`09`	`X`	`SPA`	`@0 Electromiografía @5 13`
C03	`10`	`X`	`FRE`	`@0 Stimulant dopaminergique @5 14`
C03	`10`	`X`	`ENG`	`@0 Dopamine agonist @5 14`
C03	`10`	`X`	`SPA`	`@0 Estimulante dopaminérgico @5 14`
C03	`11`	`X`	`FRE`	`@0 Pathogénie @5 17`
C03	`11`	`X`	`ENG`	`@0 Pathogenesis @5 17`
C03	`11`	`X`	`SPA`	`@0 Patogenia @5 17`
C03	`12`	`X`	`FRE`	`@0 Effet biologique @5 18`
C03	`12`	`X`	`ENG`	`@0 Biological effect @5 18`
C03	`12`	`X`	`SPA`	`@0 Efecto biológico @5 18`
C03	`13`	`X`	`FRE`	`@0 Etude cas @5 19`
C03	`13`	`X`	`ENG`	`@0 Case study @5 19`
C03	`13`	`X`	`SPA`	`@0 Estudio caso @5 19`
C03	`14`	`X`	`FRE`	`@0 Personne âgée @5 20`
C03	`14`	`X`	`ENG`	`@0 Elderly @5 20`
C03	`14`	`X`	`SPA`	`@0 Anciano @5 20`
C03	`15`	`X`	`FRE`	`@0 Mâle @5 21`
C03	`15`	`X`	`ENG`	`@0 Male @5 21`
C03	`15`	`X`	`SPA`	`@0 Macho @5 21`
C07	`01`	`X`	`FRE`	`@0 Homme`
C07	`01`	`X`	`ENG`	`@0 Human`
C07	`01`	`X`	`SPA`	`@0 Hombre`
C07	`02`	`X`	`FRE`	`@0 Système nerveux pathologie @5 45`
C07	`02`	`X`	`ENG`	`@0 Nervous system diseases @5 45`
C07	`02`	`X`	`SPA`	`@0 Sistema nervioso patología @5 45`
C07	`03`	`X`	`FRE`	`@0 Trouble neurologique @5 46`
C07	`03`	`X`	`ENG`	`@0 Neurological disorder @5 46`
C07	`03`	`X`	`SPA`	`@0 Trastorno neurológico @5 46`
C07	`04`	`X`	`FRE`	`@0 Trouble sensibilité @5 47`
C07	`04`	`X`	`ENG`	`@0 Sensitivity disorder @5 47`
C07	`04`	`X`	`SPA`	`@0 Trastorno sensibilidad @5 47`
C07	`05`	`X`	`FRE`	`@0 Electrodiagnostic @5 69`
C07	`05`	`X`	`ENG`	`@0 Electrodiagnosis @5 69`
C07	`05`	`X`	`SPA`	`@0 Electrodiagnóstico @5 69`
N21				`@1 203`
N82				`@1 PSI`

Format Inist (serveur)

NO :	PASCAL 02-0369774 INIST
ET :	Effects of apomorphine on flexor reflex and periodic limb movement
AU :	PARADISO (Guillermo); KHAN (Farooq); CHEN (Robert)
AF :	Division of Neurology, Toronto Western Hospital and The Toronto Western Research Institute, University Health Network, University of Toronto/Toronto, Ontario/Canada (1 aut., 2 aut., 3 aut.)
DT :	Publication en série; Courte communication, note brève; Niveau analytique
SO :	Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2002; Vol. 17; No. 3; Pp. 594-597; Bibl. 12 ref.
LA :	Anglais
EA :	It has been suggested that periodic leg movements (PLM) and spinal flexor reflex (FR) share common mechanisms Although dopaminergic agents improve PLM in humans and strongly influence spinal FR circuitry in animal studies, its effects on FR have not been documented in humans. We describe a 65-year-old man with PLM after overnight withdrawal of dopaminergic agents. The electromyographic pattern of spontaneous PLM closely resembled that of the FR elicited by medial plantar nerve stimulation. Thirty minutes after subcutaneous injection of apomorphine, both PLM and FR were completely abolished. These findings demonstrate that dopaminergic agents can suppress exaggerated FR in humans, and support the hypothesis of common mechanisms for PLM and FR.
CC :	002B17A01
FD :	Mouvement périodique; Membre inférieur; Impatience membre inférieur syndrome; Réflexe; Muscle fléchisseur; Apomorphine; Agoniste; Récepteur dopaminergique; Electromyographie; Stimulant dopaminergique; Pathogénie; Effet biologique; Etude cas; Personne âgée; Mâle
FG :	Homme; Système nerveux pathologie; Trouble neurologique; Trouble sensibilité; Electrodiagnostic
ED :	Periodic motion; Lower limb; Restless legs syndrome; Reflex; Flexor muscle; Agonist; Dopamine receptor; Electromyography; Dopamine agonist; Pathogenesis; Biological effect; Case study; Elderly; Male
EG :	Human; Nervous system diseases; Neurological disorder; Sensitivity disorder; Electrodiagnosis
SD :	Movimiento periódico; Miembro inferior; Acroparestesia nocturna; Reflejo; Músculo flexor; Agonista; Receptor dopaminérgico; Electromiografía; Estimulante dopaminérgico; Patogenia; Efecto biológico; Estudio caso; Anciano; Macho
LO :	INIST-20953.354000108224770260
ID :	02-0369774

Links to Exploration step

Pascal:02-0369774

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Effects of apomorphine on flexor reflex and periodic limb movement</title>
<author><name sortKey="Paradiso, Guillermo" sort="Paradiso, Guillermo" uniqKey="Paradiso G" first="Guillermo" last="Paradiso">Guillermo Paradiso</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Neurology, Toronto Western Hospital and The Toronto Western Research Institute, University Health Network, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Khan, Farooq" sort="Khan, Farooq" uniqKey="Khan F" first="Farooq" last="Khan">Farooq Khan</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Neurology, Toronto Western Hospital and The Toronto Western Research Institute, University Health Network, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Chen, Robert" sort="Chen, Robert" uniqKey="Chen R" first="Robert" last="Chen">Robert Chen</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Neurology, Toronto Western Hospital and The Toronto Western Research Institute, University Health Network, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">02-0369774</idno>
<date when="2002">2002</date>
<idno type="stanalyst">PASCAL 02-0369774 INIST</idno>
<idno type="RBID">Pascal:02-0369774</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002729</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Effects of apomorphine on flexor reflex and periodic limb movement</title>
<author><name sortKey="Paradiso, Guillermo" sort="Paradiso, Guillermo" uniqKey="Paradiso G" first="Guillermo" last="Paradiso">Guillermo Paradiso</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Neurology, Toronto Western Hospital and The Toronto Western Research Institute, University Health Network, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Khan, Farooq" sort="Khan, Farooq" uniqKey="Khan F" first="Farooq" last="Khan">Farooq Khan</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Neurology, Toronto Western Hospital and The Toronto Western Research Institute, University Health Network, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Chen, Robert" sort="Chen, Robert" uniqKey="Chen R" first="Robert" last="Chen">Robert Chen</name>
<affiliation><inist:fA14 i1="01"><s1>Division of Neurology, Toronto Western Hospital and The Toronto Western Research Institute, University Health Network, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2002">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Agonist</term>
<term>Biological effect</term>
<term>Case study</term>
<term>Dopamine agonist</term>
<term>Dopamine receptor</term>
<term>Elderly</term>
<term>Electromyography</term>
<term>Flexor muscle</term>
<term>Lower limb</term>
<term>Male</term>
<term>Pathogenesis</term>
<term>Periodic motion</term>
<term>Reflex</term>
<term>Restless legs syndrome</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Mouvement périodique</term>
<term>Membre inférieur</term>
<term>Impatience membre inférieur syndrome</term>
<term>Réflexe</term>
<term>Muscle fléchisseur</term>
<term>Apomorphine</term>
<term>Agoniste</term>
<term>Récepteur dopaminergique</term>
<term>Electromyographie</term>
<term>Stimulant dopaminergique</term>
<term>Pathogénie</term>
<term>Effet biologique</term>
<term>Etude cas</term>
<term>Personne âgée</term>
<term>Mâle</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">It has been suggested that periodic leg movements (PLM) and spinal flexor reflex (FR) share common mechanisms Although dopaminergic agents improve PLM in humans and strongly influence spinal FR circuitry in animal studies, its effects on FR have not been documented in humans. We describe a 65-year-old man with PLM after overnight withdrawal of dopaminergic agents. The electromyographic pattern of spontaneous PLM closely resembled that of the FR elicited by medial plantar nerve stimulation. Thirty minutes after subcutaneous injection of apomorphine, both PLM and FR were completely abolished. These findings demonstrate that dopaminergic agents can suppress exaggerated FR in humans, and support the hypothesis of common mechanisms for PLM and FR.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>17</s2>
</fA05>
<fA06><s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Effects of apomorphine on flexor reflex and periodic limb movement</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>PARADISO (Guillermo)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>KHAN (Farooq)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>CHEN (Robert)</s1>
</fA11>
<fA14 i1="01"><s1>Division of Neurology, Toronto Western Hospital and The Toronto Western Research Institute, University Health Network, University of Toronto</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA20><s1>594-597</s1>
</fA20>
<fA21><s1>2002</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000108224770260</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2002 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>12 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>02-0369774</s0>
</fA47>
<fA60><s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>It has been suggested that periodic leg movements (PLM) and spinal flexor reflex (FR) share common mechanisms Although dopaminergic agents improve PLM in humans and strongly influence spinal FR circuitry in animal studies, its effects on FR have not been documented in humans. We describe a 65-year-old man with PLM after overnight withdrawal of dopaminergic agents. The electromyographic pattern of spontaneous PLM closely resembled that of the FR elicited by medial plantar nerve stimulation. Thirty minutes after subcutaneous injection of apomorphine, both PLM and FR were completely abolished. These findings demonstrate that dopaminergic agents can suppress exaggerated FR in humans, and support the hypothesis of common mechanisms for PLM and FR.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17A01</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Mouvement périodique</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Periodic motion</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Movimiento periódico</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Membre inférieur</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Lower limb</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Miembro inferior</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Impatience membre inférieur syndrome</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Restless legs syndrome</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Acroparestesia nocturna</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Réflexe</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Reflex</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Reflejo</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Muscle fléchisseur</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Flexor muscle</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Músculo flexor</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Apomorphine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Agoniste</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Agonist</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Agonista</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Récepteur dopaminergique</s0>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Dopamine receptor</s0>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Receptor dopaminérgico</s0>
<s5>12</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Electromyographie</s0>
<s5>13</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Electromyography</s0>
<s5>13</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Electromiografía</s0>
<s5>13</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Stimulant dopaminergique</s0>
<s5>14</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Dopamine agonist</s0>
<s5>14</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Estimulante dopaminérgico</s0>
<s5>14</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Pathogénie</s0>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Pathogenesis</s0>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Patogenia</s0>
<s5>17</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Effet biologique</s0>
<s5>18</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Biological effect</s0>
<s5>18</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Efecto biológico</s0>
<s5>18</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Etude cas</s0>
<s5>19</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Case study</s0>
<s5>19</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Estudio caso</s0>
<s5>19</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>Personne âgée</s0>
<s5>20</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG"><s0>Elderly</s0>
<s5>20</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA"><s0>Anciano</s0>
<s5>20</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE"><s0>Mâle</s0>
<s5>21</s5>
</fC03>
<fC03 i1="15" i2="X" l="ENG"><s0>Male</s0>
<s5>21</s5>
</fC03>
<fC03 i1="15" i2="X" l="SPA"><s0>Macho</s0>
<s5>21</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Homme</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Human</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Hombre</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>45</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>45</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>45</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Trouble neurologique</s0>
<s5>46</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Neurological disorder</s0>
<s5>46</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Trastorno neurológico</s0>
<s5>46</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Trouble sensibilité</s0>
<s5>47</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Sensitivity disorder</s0>
<s5>47</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Trastorno sensibilidad</s0>
<s5>47</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Electrodiagnostic</s0>
<s5>69</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Electrodiagnosis</s0>
<s5>69</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Electrodiagnóstico</s0>
<s5>69</s5>
</fC07>
<fN21><s1>203</s1>
</fN21>
<fN82><s1>PSI</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 02-0369774 INIST</NO>
<ET>Effects of apomorphine on flexor reflex and periodic limb movement</ET>
<AU>PARADISO (Guillermo); KHAN (Farooq); CHEN (Robert)</AU>
<AF>Division of Neurology, Toronto Western Hospital and The Toronto Western Research Institute, University Health Network, University of Toronto/Toronto, Ontario/Canada (1 aut., 2 aut., 3 aut.)</AF>
<DT>Publication en série; Courte communication, note brève; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2002; Vol. 17; No. 3; Pp. 594-597; Bibl. 12 ref.</SO>
<LA>Anglais</LA>
<EA>It has been suggested that periodic leg movements (PLM) and spinal flexor reflex (FR) share common mechanisms Although dopaminergic agents improve PLM in humans and strongly influence spinal FR circuitry in animal studies, its effects on FR have not been documented in humans. We describe a 65-year-old man with PLM after overnight withdrawal of dopaminergic agents. The electromyographic pattern of spontaneous PLM closely resembled that of the FR elicited by medial plantar nerve stimulation. Thirty minutes after subcutaneous injection of apomorphine, both PLM and FR were completely abolished. These findings demonstrate that dopaminergic agents can suppress exaggerated FR in humans, and support the hypothesis of common mechanisms for PLM and FR.</EA>
<CC>002B17A01</CC>
<FD>Mouvement périodique; Membre inférieur; Impatience membre inférieur syndrome; Réflexe; Muscle fléchisseur; Apomorphine; Agoniste; Récepteur dopaminergique; Electromyographie; Stimulant dopaminergique; Pathogénie; Effet biologique; Etude cas; Personne âgée; Mâle</FD>
<FG>Homme; Système nerveux pathologie; Trouble neurologique; Trouble sensibilité; Electrodiagnostic</FG>
<ED>Periodic motion; Lower limb; Restless legs syndrome; Reflex; Flexor muscle; Agonist; Dopamine receptor; Electromyography; Dopamine agonist; Pathogenesis; Biological effect; Case study; Elderly; Male</ED>
<EG>Human; Nervous system diseases; Neurological disorder; Sensitivity disorder; Electrodiagnosis</EG>
<SD>Movimiento periódico; Miembro inferior; Acroparestesia nocturna; Reflejo; Músculo flexor; Agonista; Receptor dopaminérgico; Electromiografía; Estimulante dopaminérgico; Patogenia; Efecto biológico; Estudio caso; Anciano; Macho</SD>
<LO>INIST-20953.354000108224770260</LO>
<ID>02-0369774</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002729 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 002729 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:02-0369774
   |texte=   Effects of apomorphine on flexor reflex and periodic limb movement
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Effects of apomorphine on flexor reflex and periodic limb movement

Effects of apomorphine on flexor reflex and periodic limb movement

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri